Neuberger Berman Group’s VanEck Pharmaceutical ETF PPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $316K | Hold |
3,593
| – | – | ﹤0.01% | 1713 |
|
|
2025
Q1 | $327K | Hold |
3,593
| – | – | ﹤0.01% | 1666 |
|
|
2024
Q4 | $310K | Hold |
3,593
| – | – | ﹤0.01% | 1657 |
|
|
2024
Q3 | $341K | Hold |
3,593
| – | – | ﹤0.01% | 1632 |
|
|
2024
Q2 | $329K | Hold |
3,593
| – | – | ﹤0.01% | 1623 |
|
|
2024
Q1 | $326K | Hold |
3,593
| – | – | ﹤0.01% | 1611 |
|
|
2023
Q4 | $292K | Sell |
3,593
-5,835
| -62% | -$475K | ﹤0.01% | 1658 |
|
|
2023
Q3 | $750K | Buy |
9,428
+4,825
| +105% | +$384K | ﹤0.01% | 1338 |
|
|
2023
Q2 | $362K | Buy |
4,603
+110
| +2% | +$8.64K | ﹤0.01% | 1534 |
|
|
2023
Q1 | $347K | Buy |
4,493
+790
| +21% | +$61K | ﹤0.01% | 1558 |
|
|
2022
Q4 | $288K | Hold |
3,703
| – | – | ﹤0.01% | 1600 |
|
|
2022
Q3 | $248K | Buy |
+3,703
| New | +$248K | ﹤0.01% | 1664 |
|